ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
AIM ImmunoTech Inc

AIM ImmunoTech Inc (HXB2)

0.208
0.00
( 0.00% )
Updated: 20:01:04
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.208
Bid
0.20
Offer
0.212
Volume
0.00
0.00 Day's Range 0.00
0.178 52 Week Range 0.60
Previous Close
0.208
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
7,660
Financial Volume
-
VWAP
-

HXB2 Latest News

AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer Preliminary finding of stable disease in two...

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE...

AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®

AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen® OCALA, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”...

AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer Next safety cohort...

AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer

AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer OCALA...

AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update Year marked by growing body of promising data demonstrating Ampligen’s potential to...

AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast

AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast OCALA, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- AIM...

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research Data demonstrate...

AIM ImmunoTech Announces Launch of CEO Corner Platform

AIM ImmunoTech Announces Launch of CEO Corner Platform CEO Corner segments to provide added perspective to press releases, corporate developments and pipeline progress Provides interested...

AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update

AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update Company continues progress across Ampligen® clinical development programs Growing...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00840.20.2260.218110.22206184DE
4-0.02-8.771929824560.2280.2320.17881220.20419535DE
12-0.068-24.63768115940.2760.310.17876600.23112459DE
26-0.148-41.57303370790.3560.4360.17850480.25664062DE
52-0.238-53.36322869960.4460.60.17839760.32678636DE
156-0.3569999-63.18583419220.56499990.610.17839260.34563565DE
260-0.3569999-63.18583419220.56499990.610.17839260.34563565DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
Y920Trilogy AI Corp
0.049 €
(75.00%)
1.34k
VJFVital Metals Ltd
0.0018 €
(50.00%)
200.89k
1UR1Bee Vectoring Technologies International Inc
0.0075 €
(36.36%)
37k
1EXEXMAR NV
11.18 €
(28.21%)
8.99k
PF8European Lithium Limited
0.0398 €
(26.75%)
5.88M
CNWCodon AG
0.006 €
(-45.45%)
5k
RUOCOcean Power Technologies
0.4095 €
(-37.19%)
1.34M
BDDConico Ltd
0.0004 €
(-33.33%)
1.25k
BR00Cruz Battery Metals Corp
0.0174 €
(-32.03%)
13.5k
SQHSpearmint Resources Inc
0.0082 €
(-31.67%)
137k
PF8European Lithium Limited
0.0398 €
(26.75%)
5.88M
D7GNel ASA
0.2498 €
(-1.26%)
3.43M
AXIAtos SE
0.50 €
(-28.08%)
1.98M
REBArafura Rare Earths Ltd
0.0745 €
(-1.97%)
1.96M
RUOCOcean Power Technologies
0.4095 €
(-37.19%)
1.34M

Discussion

View Full Feed
Edward Edward 6 minutes ago
Extremely strong this morning .

CTOR is up 61.76% @ 5:21am with heavy volume trading @$1.65.

As of now no news as to what is the catalyst for the rise and interest.
CTOR
Clark6290 Clark6290 8 minutes ago
Any proof, or just a guess or fake information
FNMA
Clark6290 Clark6290 10 minutes ago
Why are you so mean. I cannot help if your GSE stock is deep red my amigo
FNMA
gregcod gregcod 10 minutes ago
I cant wait to hear what the big surprise is here jancik said she will reveal..Burba is supposed to be there too?
IBATF
Edward Edward 12 minutes ago
Extremely strong this morning .

CTOR is up 61.76% @ 5:21am with heavy volume trading @$1.65.

As of now no news as to what is the catalyst for the rise and interest.
CTOR
doc063 doc063 12 minutes ago
News today!?
RNVA
Edward Edward 13 minutes ago
Extremely strong this morning .

CTOR is up 61.76% @ 5:21am with heavy volume trading at $1.65.

As of now no news as to what is the catalyst for the rise and interest.
CTOR
ksquared ksquared 14 minutes ago
Nobody's buying it...
https://nypost.com/wp-content/uploads/sites/2/2024/12/DECEMBER03.P1_LCF.jpg?resize=400,441&quality=90&strip=all&w=750
MiamiGent MiamiGent 15 minutes ago
It's outrageous!
We ought to have a national sales tax and no filing.
Trump ought to do this immediately following Elon and Vivick firing 80% of the bloated federal bureaucracy.
pepeoil pepeoil 17 minutes ago
Maybe old Ronny Loudan and Holcomb could give old joshy one of those fake generators for his yacht and Asre could join the scam merger. They could hire bubbie and Jamie from Vyst to keep the books and bring them into the scam. Don’t forget old Jack hanks at mmex, he can build old joshy a huge re
Extremist223 Extremist223 18 minutes ago
MHRA did not complete a rapid review of DCVAX right? How long do you expect the normal review to take?
NWBO
luvwetscent luvwetscent 21 minutes ago
Could be another bashturd lurking just below the surface...God, save his soul.
ELTP
pepeoil pepeoil 22 minutes ago
Old Peter Maxwell continues to post “Good morning Shrimpers “ on his Facebook scam page for Shmp, even though they are in receivership. Bwahaaaaaaa. Shmp and Joshy should get together and merge their scams and call it scam incorporated. They could use old lying joshys yacht as a shrimp boa
TRUISM TRUISM 23 minutes ago
Kraig Biocraft Laboratories, Inc. · Full-time
Senior Scientist
Jul 2021 - Jul 2024 · 3 yrs 1 mo

•Developed and cloned piggyBac plasmids encoding spider silk genes to be expressed in silkworms for the production of spider silk.
•Successfully PCR amplified highl
KBLB
ksquared ksquared 24 minutes ago
Why meteorological and astronomical winter start on 2 different dates
Many people consider the December solstice to be the official start of winter, but for meteorologists, the new season kicks off weeks before the astronomical event.
By Monica Danielle, AccuWeather Managing Editor Upd
SilkRoad SilkRoad 24 minutes ago
I think the conversation between Larry and Kim would go something like this….

Larry: When is the web conference?

Kim: Soon. I’ll let you know right before the event.

Larry: Are you sure?

Kim: Yeah.

::: staredown:::
KBLB
chicks0123 chicks0123 25 minutes ago
Good morning CLNVers 
CLNV
Moonboy1 Moonboy1 26 minutes ago
Looks like it's trying to move a little bit.
MLGO
tradernewstip tradernewstip 30 minutes ago
$CBDW The AI Chatbot Market in 2025: Growth Prospects and the Strategic Expansion of 1606 Corporation (CBDW)
@2desire-growth-prospects-and-the-strategic-expansion-of-1606-corporation-cbdw/
CBDW
mwab52 mwab52 31 minutes ago
Good morning (RNVA-Land & Team).......🤑😎........ Go (RNVA & Team)
RNVA
RichieBoy RichieBoy 39 minutes ago
Did you see where Contrivian received another very prestigious award from the IT industry? Usually holding companies are existential conduits for high net worth individuals. Long shot I know but, you don't suppose Michael Balkin has any connections with Durham Black or whatever Patrick Shutt calls h
AFFU
tradernewstip tradernewstip 41 minutes ago
$ILLR News : Creator-Centric Triller: Sean Kim's Strategy for Social Platform Success
Los Angeles, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Triller Group Inc. (Nasdaq: ILLR) ("Triller Group" or "the Company") revealed a momentous milestone in its evolution by introducing the latest iteration of Tril
ILLR
IB_ IB_ 46 minutes ago
What ya think ??????????

IB_🤴
SXOOF
IB_ IB_ 46 minutes ago
What ya think ??????????

IB_🤴
SXOOF